# Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors

> **NCT03968653** · PHASE1 · TERMINATED · sponsor: **Debiopharm International SA** · enrollment: 76 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Debio 0123
- **DRUG:** Carboplatin
- **DRUG:** Debio 0123
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT03968653
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-30
- **Primary completion:** 2025-10-23
- **Final completion:** 2025-10-23
- **Target enrollment:** 76 (ACTUAL)
- **Why stopped:** This trial was concluded for strategic reasons.
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03968653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03968653, "Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03968653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*